Taste-masked nanoparticles containing Saquinavir for pediatric oral administration

Mater Sci Eng C Mater Biol Appl. 2020 Dec:117:111315. doi: 10.1016/j.msec.2020.111315. Epub 2020 Aug 4.

Abstract

This research has aimed to improve the stability and taste-masking properties by developing nanostructured dosage forms containing Saquinavir. Liquid formulations were developed using Eudragit RS100® and Pullulan as polymers. The physicochemical characteristics, stability, in vitro drug release, morphology, mucoadhesion and taste masking capacity were evaluated. The Saquinavir-nanoparticles had average diameters between 136 and 158 nm, with a Span below 1.4. These formulations presented a drug content above 80%, a high encapsulation efficiency (>97%), slightly acidic pH levels, low dynamic viscosity and controlled drug release. Electron microscopy revealed irregular spherical nanoparticles. The formulations prepared with higher amounts of Eudragit RS100® had greater mucoadhesion. Both polymers were able to improve drug stabilization, taste-masking properties and protection against drug cytotoxicity. The Saquinavir-nanoparticles exhibited stability and control releasing properties, thus making it a promising liquid dosage form with taste-masking properties intended for application in pediatric treatment.

Keywords: Electronic tongue; Eudragit RS100®; Nanoparticles; Pullulan; Saquinavir; Stability.

MeSH terms

  • Administration, Oral
  • Child
  • Drug Compounding
  • Drug Liberation
  • Humans
  • Nanoparticles*
  • Saquinavir* / pharmacology
  • Solubility
  • Taste

Substances

  • Saquinavir